{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:51:38Z","timestamp":1789177898713,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1038\/bmt.2017.71","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T13:41:29Z","timestamp":1494855689000},"page":"883-888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A new time-dependent approach for assessment of the impact of invasive aspergillosis shows effect on short- but not on long-term survival of patients with AML or high-risk MDS"],"prefix":"10.1038","volume":"52","author":[{"given":"R J","family":"van de Peppel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"von dem Borne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"le Cessie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G J","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"key":"BFbmt201771_CR1","doi-asserted-by":"publisher","first-page":"e390","DOI":"10.1038\/bcj.2016.3","volume":"6","author":"H Bower","year":"2016","unstructured":"Bower H, Andersson TM, Bjorkholm M, Dickman PW, Lambert PC, Derolf AR . Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life. Blood Cancer J 2016; 6: e390.","journal-title":"Blood Cancer J"},{"key":"BFbmt201771_CR2","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3109\/0284186X.2014.889851","volume":"53","author":"BK Shah","year":"2014","unstructured":"Shah BK, Ghimire KB . Improved survival among older acute myeloid leukemia patients-a population-based study. Acta Oncol 2014; 53: 935\u2013938.","journal-title":"Acta Oncol"},{"key":"BFbmt201771_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s12185-008-0184-2","volume":"88","author":"J Auberger","year":"2008","unstructured":"Auberger J, Lass-Florl C, Ulmer H, Nogler-Semenitz E, Clausen J, Gunsilius E et al. Significant alterations in the epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 2008; 88: 508\u2013515.","journal-title":"Int J Hematol"},{"key":"BFbmt201771_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/318483","volume":"32","author":"SJ Lin","year":"2001","unstructured":"Lin SJ, Schranz J, Teutsch SM . Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358\u2013366.","journal-title":"Clin Infect Dis"},{"key":"BFbmt201771_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12026-012-8274-x","volume":"52","author":"I Mirkov","year":"2012","unstructured":"Mirkov I, Stosic-Grujicic S, Kataranovski M . Host immune defense against Aspergillus fumigatus: insight from experimental systemic (disseminated) infection. Immunol Res 2012; 52: 120\u2013126.","journal-title":"Immunol Res"},{"key":"BFbmt201771_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fmicb.2012.00129","volume":"3","author":"C Tokarski","year":"2012","unstructured":"Tokarski C, Hummert S, Mech F, Figge MT, Germerodt S, Schroeter A et al. Agent-based modeling approach of immune defense against spores of opportunistic human pathogenic fungi. Front Microbiol 2012; 3: 129.","journal-title":"Front Microbiol"},{"issue":"Suppl 1","key":"BFbmt201771_CR7","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.3109\/13693786.2010.505204","volume":"49","author":"JW Baddley","year":"2011","unstructured":"Baddley JW . Clinical risk factors for invasive aspergillosis. Med Mycol 2011; 49 (Suppl 1): S7\u2013S12.","journal-title":"Med Mycol"},{"issue":"Suppl 1","key":"BFbmt201771_CR8","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.3109\/13693786.2010.509138","volume":"49","author":"M Caira","year":"2011","unstructured":"Caira M, Mancinelli M, Leone G, Pagano L . Invasive aspergillosis in acute leukemias: old and new risk factors and epidemiological trends. Med Mycol 2011; 49 (Suppl 1): S13\u2013S16.","journal-title":"Med Mycol"},{"key":"BFbmt201771_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/mmy\/myu036","volume":"52","author":"RJ van de Peppel","year":"2014","unstructured":"van de Peppel RJ, Dekkers OM, von dem Borne PA, de Boer MG . Relapsed and secondary disease drive the risk profile for invasive aspergillosis prior to stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome. Med Mycol 2014; 52: 699\u2013705.","journal-title":"Med Mycol"},{"key":"BFbmt201771_CR10","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1053\/j.seminoncol.2008.04.015","volume":"35","author":"E Meijer","year":"2008","unstructured":"Meijer E, Cornelissen JJ . Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: weighing prognostic markers predicting relapse and risk factors for non-relapse mortality. Semin Oncol 2008; 35: 449\u2013457.","journal-title":"Semin Oncol"},{"key":"BFbmt201771_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jgo.2015.10.182","volume":"7","author":"B Tawfik","year":"2016","unstructured":"Tawfik B, Pardee TS, Isom S, Sliesoraitis S, Winter A, Lawrence J et al. Comorbidity, age, and mortality among adults treated intensively for acute myeloid leukemia (AML). J Geriatr Oncol 2016; 7: 24\u201331.","journal-title":"J Geriatr Oncol"},{"key":"BFbmt201771_CR12","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1080\/10428190600709150","volume":"47","author":"AM Tsimberidou","year":"2006","unstructured":"Tsimberidou AM, Estey E . Induction mortality risk in adult acute myeloid leukemia. Leuk Lymphoma 2006; 47: 1199\u20131200.","journal-title":"Leuk Lymphoma"},{"key":"BFbmt201771_CR13","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813\u20131821.","journal-title":"Clin Infect Dis"},{"key":"BFbmt201771_CR14","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1097\/EDE.0b013e3181810e29","volume":"19","author":"TJ VanderWeele","year":"2008","unstructured":"VanderWeele TJ, Hernan MA, Robins JM . Causal directed acyclic graphs and the direction of unmeasured confounding bias. Epidemiology 2008; 19: 720\u2013728.","journal-title":"Epidemiology"},{"key":"BFbmt201771_CR15","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s00134-011-2344-8","volume":"37","author":"G Burghi","year":"2011","unstructured":"Burghi G, Lemiale V, Seguin A, Lambert J, Lacroix C, Canet E et al. Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis. Intensive Care Med 2011; 37: 1605\u20131612.","journal-title":"Intensive Care Med"},{"key":"BFbmt201771_CR16","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1055\/s-0035-1562893","volume":"36","author":"KS Gregg","year":"2015","unstructured":"Gregg KS, Kauffman CA . Invasive aspergillosis: epidemiology, clinical aspects, and treatment. Semin Respir Crit Care Med 2015; 36: 662\u2013672.","journal-title":"Semin Respir Crit Care Med"},{"key":"BFbmt201771_CR17","doi-asserted-by":"publisher","first-page":"e0120370","DOI":"10.1371\/journal.pone.0120370","volume":"10","author":"C Garcia-Vidal","year":"2015","unstructured":"Garcia-Vidal C, Peghin M, Cervera C, Gudiol C, Ruiz-Camps I, Moreno A et al. Causes of death in a contemporary cohort of patients with invasive aspergillosis. PLoS ONE 2015; 10: e0120370.","journal-title":"PLoS ONE"},{"key":"BFbmt201771_CR18","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s12185-012-1210-y","volume":"96","author":"M Kurosawa","year":"2012","unstructured":"Kurosawa M, Yonezumi M, Hashino S, Tanaka J, Nishio M, Kaneda M et al. Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies. Int J Hematol 2012; 96: 748\u2013757.","journal-title":"Int J Hematol"},{"key":"BFbmt201771_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.5045\/kjh.2012.47.4.255","volume":"47","author":"JY Lee","year":"2012","unstructured":"Lee JY, Jung CW, Kim K, Jang JH . Impact of previous invasive pulmonary aspergillosis on the outcome of allogeneic hematopoietic stem cell transplantation. Korean J Hematol 2012; 47: 255\u2013259.","journal-title":"Korean J Hematol"},{"key":"BFbmt201771_CR20","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s10096-011-1397-5","volume":"31","author":"M Michallet","year":"2012","unstructured":"Michallet M, Benet T, Sobh M, Kraghel S, El Hamri M, Cannas G et al. Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients. Eur J Clin Microbiol Infect Dis 2012; 31: 991\u2013997.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"BFbmt201771_CR21","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.3324\/haematol.2011.058255","volume":"97","author":"G Salmeron","year":"2012","unstructured":"Salmeron G, Porcher R, Bergeron A, Robin M, Peffault de Latour R, Ferry C et al. Persistent poor long-term prognosis of allogeneic hematopoietic stem cell transplant recipients surviving invasive aspergillosis. Haematologica 2012; 97: 1357\u20131363.","journal-title":"Haematologica"},{"key":"BFbmt201771_CR22","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.leukres.2014.01.007","volume":"38","author":"C Girmenia","year":"2014","unstructured":"Girmenia C, Micozzi A, Piciocchi A, Gentile G, Di Caprio L, Nasso D et al. Invasive fungal diseases during first induction chemotherapy affect complete remission achievement and long-term survival of patients with acute myeloid leukemia. Leuk Res 2014; 38: 469\u2013474.","journal-title":"Leuk Res"},{"key":"BFbmt201771_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3109\/00365548.2011.623311","volume":"44","author":"L Li","year":"2012","unstructured":"Li L, Wang J, Zhang W, Yang J, Chen L, Lv S . Risk factors for invasive mold infections following allogeneic hematopoietic stem cell transplantation: a single center study of 190 recipients. Scand J Infect Dis 2012; 44: 100\u2013107.","journal-title":"Scand J Infect Dis"},{"key":"BFbmt201771_CR24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/bmt.2009.39","volume":"44","author":"M Mikulska","year":"2009","unstructured":"Mikulska M, Raiola AM, Bruno B, Furfaro E, Van Lint MT, Bregante S et al. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients. Bone Marrow Transplant 2009; 44: 361\u2013370.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201771_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s15010-016-0873-3","volume":"44","author":"E Hardak","year":"2016","unstructured":"Hardak E, Avivi I, Berkun L, Raz-Pasteur A, Lavi N, Geffen Y et al. Polymicrobial pulmonary infection in patients with hematological malignancies: prevalence, co-pathogens, course and outcome. Infection 2016; 44: 491\u2013497.","journal-title":"Infection"},{"key":"BFbmt201771_CR26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.3109\/00365548.2013.776173","volume":"45","author":"M Kikuchi","year":"2013","unstructured":"Kikuchi M, Nakasone H, Mitani K, Gotoh M, Kobayashi A, Kurita N et al. Retrospective assessment of secondary prophylaxis for invasive aspergillosis in neutropenic hematology patients and identification of risk factors for relapse of fungal disease. Scand J Infect Dis 2013; 45: 531\u2013536.","journal-title":"Scand J Infect Dis"},{"key":"BFbmt201771_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/leu.2008.352","volume":"23","author":"N Basara","year":"2009","unstructured":"Basara N, Schulze A, Wedding U, Mohren M, Gerhardt A, Junghanss C et al. Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission. Leukemia 2009; 23: 635\u2013640.","journal-title":"Leukemia"},{"key":"BFbmt201771_CR28","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/sj.bmt.1700761","volume":"19","author":"E Jourdan","year":"1997","unstructured":"Jourdan E, Maraninchi D, Reiffers J, Gluckman E, Rio B, Jouet JP et al. Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Societe Francaise de Greffe de Moelle (SFGM). Bone Marrow Transplant 1997; 19: 875\u2013881.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201771_CR29","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jgar.2015.09.002","volume":"3","author":"A Busca","year":"2015","unstructured":"Busca A, Tortorano AM, Pagano L . Reviewing the importance and evolution of fungal infections and potential antifungal resistance in haematological patients. J Glob Antimicrob Resist 2015; 3: 237\u2013241.","journal-title":"J Glob Antimicrob Resist"},{"key":"BFbmt201771_CR30","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/cid\/ciu911","volume":"60","author":"R Herbrecht","year":"2015","unstructured":"Herbrecht R, Patterson TF, Slavin MA, Marchetti O, Maertens J, Johnson EM et al. Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group. Clin Infect Dis 2015; 60: 713\u2013720.","journal-title":"Clin Infect Dis"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201771.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201771","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2017.71","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201771.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T20:03:42Z","timestamp":1648065822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["BFbmt201771"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2017.71","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]},"assertion":[{"value":"8 December 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}